67 related articles for article (PubMed ID: 8958365)
1. Incidence of and risk factors for myelodysplastic syndrome in patients with rheumatologic diseases.
Kim YE; Ahn SM; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
Rheumatology (Oxford); 2024 May; 63(5):1305-1312. PubMed ID: 37498607
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune Syndromes Presenting as a Paraneoplastic Manifestation of Myelodysplastic Syndromes: Clinical Features, Course, Treatment and Outcome.
Williamson BT; Foltz L; Leitch HA
Hematol Rep; 2016 May; 8(2):6480. PubMed ID: 27499837
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Dilemma of Paraneoplastic Rheumatic Disorders: Case Series and Narrative Review.
Cho Y; Anderson EW; Guevara SJ; Miyara SJ; Maria N; Metz CN; Zafeiropoulos S; Giannis D; Wang J; Abidoye O; Mumford JM; Aronsohn J; Molmenti E; Sohail H
Cureus; 2021 Nov; 13(11):e19993. PubMed ID: 34984145
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome: A case report and literature review.
Sun C; Luo Y; Tong H; Xu G; Lin J
Medicine (Baltimore); 2018 Jun; 97(25):e11179. PubMed ID: 29924032
[TBL] [Abstract][Full Text] [Related]
5. Neutropenia in the Elderly: A Rheumatology Perspective.
Yeoh SA; Fox C; Hull R
Drugs Aging; 2016 Aug; 33(8):585-601. PubMed ID: 27402172
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Rheumatologic disorders in patients with Myelodysplastic Syndromes: A cross-sectional study.
Mobini M; Shekarriz R; Ali Mohammad Pour R; Zakeri S
Int J Hematol Oncol Stem Cell Res; 2015 Jan; 9(1):22-5. PubMed ID: 25802697
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases.
Mekinian A; Braun T; Decaux O; Falgarone G; Toussirot E; Raffray L; Omouri M; Gombert B; De Wazieres B; Buchdaul AL; Ziza JM; Launay D; Denis G; Madaule S; Rose C; Grignano E; Fenaux P; Fain O;
Medicine (Baltimore); 2014 Jan; 93(1):1-10. PubMed ID: 24378738
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.
Al Ustwani O; Ford LA; Sait SJ; Block AM; Barcos M; Vigil CE; Griffiths EA; Thompson JE; Wang ES; Ambrus J; Wetzler M
Leuk Res; 2013 Aug; 37(8):894-9. PubMed ID: 23692654
[TBL] [Abstract][Full Text] [Related]
9. Metal-on-metal joint bearings and hematopoetic malignancy.
Wagner P; Olsson H; Ranstam J; Robertsson O; Zheng MH; Lidgren L
Acta Orthop; 2012 Dec; 83(6):553-8. PubMed ID: 23140092
[TBL] [Abstract][Full Text] [Related]
10. Rheumatologic manifestations of benign and malignant haematological disorders.
Ravindran V; Anoop P
Clin Rheumatol; 2011 Sep; 30(9):1143-9. PubMed ID: 21698399
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndrome: An update on diagnosis and therapy.
Koppel A; Schiller G
Curr Hematol Malig Rep; 2009 Jan; 4(1):10-6. PubMed ID: 20425433
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndrome: an update on diagnosis and therapy.
Koppel A; Schiller G
Curr Oncol Rep; 2008 Sep; 10(5):372-8. PubMed ID: 18706264
[TBL] [Abstract][Full Text] [Related]
13. Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases.
Kuzmich PV; Ecker GA; Karsh J
J Rheumatol; 1994 Sep; 21(9):1649-54. PubMed ID: 7799343
[TBL] [Abstract][Full Text] [Related]
14. [Rheumatological manifestations associated with myelodysplastic and myeloproliferative syndromes].
Pajus I; Amor B
Rev Rhum Mal Osteoartic; 1992 Jan; 59(1):11-6. PubMed ID: 1579839
[TBL] [Abstract][Full Text] [Related]
15. [Mixed myelodysplastic and myeloproliferative syndromes].
Neuwirtová R; Mociková K; Jelínek J; Musilová J; Havlícek F; Adamkov M; Michalová K; Cermák J; Jonásová A; Smolíková A; Straub J; Tothová E; Voglová J; Vozobulová V; Waltrová L
Cas Lek Cesk; 1997 Dec; 136(23):724-9. PubMed ID: 9476375
[TBL] [Abstract][Full Text] [Related]
16. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
[TBL] [Abstract][Full Text] [Related]
17. [Systemic diseases in myelodysplastic syndromes].
Hebbar M; Hebbar-Savéan K; Fenaux P
Rev Med Interne; 1995; 16(12):897-904. PubMed ID: 8570952
[TBL] [Abstract][Full Text] [Related]
18. Rheumatic manifestations of the myelodysplastic syndromes: a comparative study.
Chandran G; Ahern MJ; Seshadri P; Coghlan D
Aust N Z J Med; 1996 Oct; 26(5):683-8. PubMed ID: 8958365
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
